These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 21829026)
21. Combined approach to hepatocellular carcinoma: a new treatment concept for nonresectable disease. Strebel BM; Dufour JF Expert Rev Anticancer Ther; 2008 Nov; 8(11):1743-9. PubMed ID: 18983234 [TBL] [Abstract][Full Text] [Related]
22. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Sasaki A; Kai S; Iwashita Y; Hirano S; Ohta M; Kitano S Cancer; 2005 Jan; 103(2):299-306. PubMed ID: 15578688 [TBL] [Abstract][Full Text] [Related]
23. Multidisciplinary management of nonresectable hepatocellular carcinoma. Park HC; Seong J; Tanaka M; Zeng ZC; Lim HY; Guan S; Bae SH; Tak WY Oncology; 2011; 81 Suppl 1():134-40. PubMed ID: 22212947 [TBL] [Abstract][Full Text] [Related]
24. Treatment strategies for hepatocellular carcinoma with extrahepatic metastasis. Long HY; Huang TY; Xie XY; Long JT; Liu BX World J Clin Cases; 2021 Jul; 9(21):5754-5768. PubMed ID: 34368295 [TBL] [Abstract][Full Text] [Related]
25. Treatment options for hepatocellular carcinoma. Sandhu DS; Tharayil VS; Lai JP; Roberts LR Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372 [TBL] [Abstract][Full Text] [Related]
26. Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan. Kudo M; Ueshima K Oncology; 2010 Jul; 78 Suppl 1():154-66. PubMed ID: 20616599 [TBL] [Abstract][Full Text] [Related]
28. Opportunities for targeted therapies in hepatocellular carcinoma. Thomas MB; Abbruzzese JL J Clin Oncol; 2005 Nov; 23(31):8093-108. PubMed ID: 16258107 [TBL] [Abstract][Full Text] [Related]
29. Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies. Lord R; Suddle A; Ross PJ Int J Clin Pract; 2011 Feb; 65(2):182-8. PubMed ID: 21235699 [TBL] [Abstract][Full Text] [Related]
30. [A case report of hepatocellular carcinoma with hepatic and portal venous tumor thrombus and multiple intrahepatic metastasis who survived over 1 year after the operation with combined locoregional chemotherapy]. Shimizu J; Nagano H; Sakon M; Dono K; Takeda Y; Kishimoto S; Eguchi H; Miyamoto A; Kondo M; Nakamori S; Umeshita K; Nakamura H; Wakasa K; Monden M Gan To Kagaku Ryoho; 1999 Oct; 26(12):1895-9. PubMed ID: 10560420 [TBL] [Abstract][Full Text] [Related]
31. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585 [TBL] [Abstract][Full Text] [Related]
32. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection. Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326 [TBL] [Abstract][Full Text] [Related]
33. Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases. Jang JW; Kay CS; You CR; Kim CW; Bae SH; Choi JY; Yoon SK; Han CW; Jung HS; Choi IB Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):412-8. PubMed ID: 18963538 [TBL] [Abstract][Full Text] [Related]
34. Systemic therapy of hepatocellular carcinoma: are we making progress? Roxburgh P; Evans TR Adv Ther; 2008 Nov; 25(11):1089-104. PubMed ID: 18972075 [TBL] [Abstract][Full Text] [Related]
35. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages. D'Avola D; IƱarrairaegui M; Pardo F; Rotellar F; Marti P; Bilbao JI; Martinez-Cuesta A; Benito A; Alegre F; MauleĆ³n E; Herrero JI; Quiroga J; Prieto J; Sangro B Ann Surg Oncol; 2011 Jul; 18(7):1964-71. PubMed ID: 21267791 [TBL] [Abstract][Full Text] [Related]
36. Imaging assessment of hepatocellular carcinoma response to locoregional and systemic therapy. Yaghmai V; Besa C; Kim E; Gatlin JL; Siddiqui NA; Taouli B AJR Am J Roentgenol; 2013 Jul; 201(1):80-96. PubMed ID: 23789661 [TBL] [Abstract][Full Text] [Related]
37. Systemic therapies for hepatocellular carcinoma. Ge S; Huang D Drug Discov Ther; 2015 Oct; 9(5):352-62. PubMed ID: 26632544 [TBL] [Abstract][Full Text] [Related]
38. The present and the future landscape of treatment of advanced hepatocellular carcinoma. Rimassa L; Santoro A Dig Liver Dis; 2010 Jul; 42 Suppl 3():S273-80. PubMed ID: 20547314 [TBL] [Abstract][Full Text] [Related]
39. [A long-term survival case of hepatocellular carcinoma with lymph node metastasis on the posterior surface of the pancreas head and portal vein tumor thrombus successfully treated with hepatopancreatoduodenectomy and adjuvant interferon-alpha and 5-fluorouracil combination therapy]. Tomimaru Y; Kobayashi S; Nagano H; Murakami M; Wada H; Marubashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Wakasa K; Doki Y; Mori M Gan To Kagaku Ryoho; 2009 Nov; 36(12):2389-91. PubMed ID: 20037432 [TBL] [Abstract][Full Text] [Related]
40. Recent advances in the treatment of hepatocellular carcinoma. Singal AG; Marrero JA Curr Opin Gastroenterol; 2010 May; 26(3):189-95. PubMed ID: 20224395 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]